What is the Org number of NeuroGyn Norr AB?

NeuroGyn Norr AB is registered with Bolagsverket / SCB under Org 5566708284.

What is the revenue of NeuroGyn Norr AB?

NeuroGyn Norr AB reported revenue of SEK 683K in 2024.

How many employees does NeuroGyn Norr AB have?

NeuroGyn Norr AB employs 1 people as of the latest annual report.

Who is the CEO of NeuroGyn Norr AB?

Johan Anders Pettersson is Chief Auditor of NeuroGyn Norr AB, in role since 2022.

Who is the chairman of NeuroGyn Norr AB?

Di Zhu chairs the board of NeuroGyn Norr AB, in role since 2022.

Where is NeuroGyn Norr AB headquartered?

NeuroGyn Norr AB's registered address is Segelvägen 8.

Riskpilot← Back to search

Sign inGet full access

NeuroGyn Norr AB

ABActive

Org 5566708284Segelvägen 8, 914 31 NordmalingResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20041 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2020	2021	2022	2023	2024
Revenue	2 117	1 945	1 457	682	683
Staff expenses	—	—	−899	−307	−211
EBITDA	639	212	−217	−184	3
Depreciation & amort.	−3	−5	−8	−5	−4
EBIT	636	207	−225	−189	−0
Net financials	123	−266	−116	−141	−10
Profit before tax	649	68	−231	−330	−11
Tax	−76	−82	—	—	−5
Net profit	573	−14	−231	−330	−16

Balance sheet

SEK thousands

Item	2020	2021	2022	2023	2024
Total assets	1 620	1 333	984	662	1 185
Equity	888	574	243	163	147
Long-term debt	0	0	—	—	—
Short-term debt	622	649	741	499	1 038
Total debt	622	649	741	499	1 038

Financial ratios

5-year trend

EBITDA margin

0.5%

This company

15.8%

Market median

-97% vs market

20202024

Equity ratio

12.4%

This company

38.2%

Market median

-68% vs market

20202024

Return on equity

-10.7%

This company

18.4%

Market median

-158% vs market

20202024

Net profit margin

-2.3%

This company

8.1%

Market median

-128% vs market

20202024

Asset turnover

0.58×

This company

1.12×

Market median

-48% vs market

20202024

Debt / equity

7.06×

This company

0.62×

Market median

-1039% vs market

20202024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31

NeuroGyn Norr AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on NeuroGyn Norr AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on NeuroGyn Norr AB